These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical evaluation of hesper-C therapy. JAMES AP Ohio State Med J; 1957 Apr; 53(4):413-4. PubMed ID: 13419286 [No Abstract] [Full Text] [Related]
6. [Some clinical aspects of capillary fragility; ascorbic acid and rutin therapy]. DE PENNA CP Hospital (Rio J); 1953 Jun; 43(6):781-806. PubMed ID: 13095977 [No Abstract] [Full Text] [Related]
7. [Changes in the thromboelastogram by means of a prolonged action hemostatic principle]. KOPP A Geburtshilfe Frauenheilkd; 1956 Feb; 16(2):154-60. PubMed ID: 13318335 [No Abstract] [Full Text] [Related]
8. Hesper-C in acne. PEIRCE RJ; BUKER WH; BRODY SL Ohio State Med J; 1959 Jan; 55(1):59. PubMed ID: 13613683 [No Abstract] [Full Text] [Related]
9. Therapy in capillary fragility. MARTIN GJ J S C Med Assoc; 1957 May; 53(5):167-72. PubMed ID: 13429650 [No Abstract] [Full Text] [Related]
11. The use of cepevit (ascorbic acid plus P factors) in drug-induced hypoprothrombinemia. SHAPIRO S; SPITZER JM Angiology; 1954 Apr; 5(2):64-71. PubMed ID: 13148649 [No Abstract] [Full Text] [Related]
12. [Control of capillary resistance in surgery]. CAITHAML W; PAUL K Wien Med Wochenschr; 1955 Oct; 105(43):900-1. PubMed ID: 13291835 [No Abstract] [Full Text] [Related]
13. Epistaxis; treatment with a new citrus flavinoid compound combined with vitamin K. SCAL JC Eye Ear Nose Throat Mon; 1956 Nov; 35(11):719-21. PubMed ID: 13365640 [No Abstract] [Full Text] [Related]
14. [Antihemorrhagic effects of vitamins C, P and K in surgery]. CLAUDIO F G Ital Chir; 1954 Nov; 10(11):874-86. PubMed ID: 14366321 [No Abstract] [Full Text] [Related]
15. [Importance of some vitamins in therapy of thromboembolism]. NAEGELI T; MATIS P Int Z Vitaminforsch Beih; 1957; 27(3):324-33. PubMed ID: 13428392 [No Abstract] [Full Text] [Related]
16. Treatment at the maternity centre and its results. SAURAMO H Ann Chir Gynaecol Fenn; 1952; 41(4):264-70. PubMed ID: 13017053 [No Abstract] [Full Text] [Related]
20. The use of the bioflavonoid compounds in the prevention or reduction in severity of erythroblastosis fetalis. JACOBS WM Surg Gynecol Obstet; 1956 Aug; 103(2):233-6. PubMed ID: 13352150 [No Abstract] [Full Text] [Related] [Next] [New Search]